Narsimha Shibroor Kamath 's most recent trade in Bliss GVS Pharma Ltd. was a Acquisition of 77,000 Equity Shares done at an average price of Rs. 127.5 . Disclosure was reported to the exchange on Feb. 21, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Narsimha Shibroor Kamath 's has made SAST transactions in Bliss GVS Pharma Ltd. recently where a Acquisition of 100,000 shares done . Disclosure was reported to the exchange on Feb. 21, 2025.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bliss GVS Pharma | Narsimha Shibroor Kamath & PACs | Promoter | Acquisition | 10 Mar 2025 | 100,000 | 32,437,024 (30.78%) | 0.09% | - | 18 Feb 2025 19 Feb 2025 |
SAST (29(2)) | - | Market | |
| Bliss GVS Pharma | Mr. Narsimha Shibroor Kamath | Promoter | Acquisition | 21 Feb 2025 | 77,000 | 32,414,024 (30.76%) | 0.07% | 127.5 | 9,819,293 | 18 Feb 2025 18 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Bliss GVS Pharma | Mr. Narsimha Shibroor Kamath | Promoter | Acquisition | 21 Feb 2025 | 23,000 | 32,437,024 (30.78%) | 0.02% | 133.6 | 3,072,625 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Bliss GVS Pharma | Narsimha Shibroor Kamath & PACs | Promoter | Acquisition | 07 Nov 2024 | 380,000 | 32,337,024 (30.75%) | 0.36% | - | 28 Oct 2024 29 Oct 2024 |
SAST (29(2)) | - | Market | |
| Bliss GVS Pharma | Narsimha Shibroor Kamath | Promoter | Acquisition | 31 Oct 2024 | 200,000 | 32,337,024 (30.75%) | 0.19% | 122.5 | 24,491,967 | 29 Oct 2024 29 Oct 2024 |
Insider Trading | Equity Shares | Market Purchase |
| Bliss GVS Pharma | Narsimha Shibroor Kamath | Promoter | Acquisition | 31 Oct 2024 | 180,000 | 32,137,024 (30.56%) | 0.17% | 115.8 | 20,850,543 | 28 Oct 2024 28 Oct 2024 |
Insider Trading | Equity Shares | Market Purchase |
| Bliss GVS Pharma | Narsimha Shibroor Kamath & PACs | Promoter | Acquisition | 02 Mar 2023 | 300,000 | 31,957,024 (30.68%) | 0.29% | - | 24 Feb 2023 24 Feb 2023 |
SAST (29(2)) | - | Market | |
| Bliss GVS Pharma | Mr. Narsimha Shibroor Kamath | Promoter | Acquisition | 01 Mar 2023 | 300,000 | 31,957,024 (30.68%) | 0.29% | 79.1 | 23,724,714 | 24 Feb 2023 24 Feb 2023 |
Insider Trading | Equity Shares | Market Purchase |
| Bliss GVS Pharma | Narsimha Shibroor Kamath & PACs | Promoter | Acquisition | 21 Feb 2023 | 300,000 | 31,657,024 (30.39%) | 0.29% | - | 15 Feb 2023 16 Feb 2023 |
SAST (29(2)) | - | Market | |
| Bliss GVS Pharma | Mr. Narsimha Shibroor Kamath | Promoter | Acquisition | 18 Feb 2023 | 100,000 | 31,657,024 (30.39%) | 0.10% | 78.0 | 7,797,497 | 16 Feb 2023 16 Feb 2023 |
Insider Trading | Equity Shares | Market Purchase |
| Bliss GVS Pharma | Mr. Narsimha Shibroor Kamath | Promoter | Acquisition | 18 Feb 2023 | 200,000 | 31,557,024 (30.30%) | 0.19% | 76.9 | 15,386,242 | 15 Feb 2023 15 Feb 2023 |
Insider Trading | Equity Shares | Market Purchase |
| Bliss GVS Pharma | Narsimha Shibroor Kamath | Promoter | Disposal | 30 Mar 2022 | 3,000,000 | 31,357,024 (30.24%) | 2.90% | - | 29 Mar 2022 29 Mar 2022 |
SAST (29(2)) | - | Inter-se Transfer / Gift | |
| Bliss GVS Pharma | Mr. Narsimha Shibroor Kamath | Promoter | Disposal | 30 Mar 2022 | 3,000,000 | 31,357,024 (30.24%) | 2.89% | 67.0 | 200,850,000 | 29 Mar 2022 29 Mar 2022 |
Insider Trading | Equity Shares | Inter-se Transfer |